Literature DB >> 16586043

Recurrent congenital heart block in neonatal lupus.

Maria C Escobar1, José A Gómez-Puerta, Dimpna Albert, Queralt Ferrer, Josep Girona.   

Abstract

Congenital heart block (CHB) is the main complication of neonatal lupus (NL) and is strongly associated with the presence of anti-SSA/Ro and anti-SSB/La antibodies. The recurrence of CHB in subsequent pregnancies in mothers with these antibodies is uncommon, occurring in approximately 15% of cases. We describe here a case of recurrent CHB in a previously asymptomatic mother with Sjögren syndrome and discuss the current strategies for the prevention and treatment of CHB in NL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586043     DOI: 10.1007/s10067-006-0282-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

Review 1.  Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach.

Authors:  Jill P Buyon; Robert M Clancy
Journal:  Semin Arthritis Rheum       Date:  2003-12       Impact factor: 5.532

2.  Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al.

Authors:  Risto Kaaja; Heikki Julkunen
Journal:  Arthritis Rheum       Date:  2003-01

3.  Birth order, gender and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling.

Authors:  Daniel G Solomon; Ann Rupel; Jill P Buyon
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 4.  Neonatal lupus: long-term outcomes of mothers and children and recurrence rate.

Authors:  A Brucato; F Franceschini; J P Buyon
Journal:  Clin Exp Rheumatol       Date:  1997 Sep-Oct       Impact factor: 4.473

Review 5.  Neonatal lupus: basic research and clinical perspectives.

Authors:  Jill P Buyon; Robert M Clancy
Journal:  Rheum Dis Clin North Am       Date:  2005-05       Impact factor: 2.670

6.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

Review 7.  [Neonatal lupus syndrome: review of the literature].

Authors:  N Costedoat-Chalumeau; Z Amoura; D Le Thi Hong; S Georgin; D Vauthier; D Sebbouh; C Francès; E Villain; B Wechsler; J-C Piette
Journal:  Rev Med Interne       Date:  2003-10       Impact factor: 0.728

8.  A new therapeutic approach to the fetus with congenital complete heart block: preemptive, targeted therapy with dexamethasone.

Authors:  D Rosenthal; M Druzin; C Chin; A Dubin
Journal:  Obstet Gynecol       Date:  1998-10       Impact factor: 7.661

9.  Autoantibody-associated congenital heart block: outcome in mothers and children.

Authors:  J Waltuck; J P Buyon
Journal:  Ann Intern Med       Date:  1994-04-01       Impact factor: 25.391

10.  Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block.

Authors:  H Julkunen; R Kaaja; E Wallgren; K Teramo
Journal:  Obstet Gynecol       Date:  1993-07       Impact factor: 7.661

View more
  1 in total

Review 1.  IgG placental transfer in healthy and pathological pregnancies.

Authors:  Patricia Palmeira; Camila Quinello; Ana Lúcia Silveira-Lessa; Cláudia Augusta Zago; Magda Carneiro-Sampaio
Journal:  Clin Dev Immunol       Date:  2011-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.